European Commission authorises first-ever rare blood condition drug
September 4, 2018Manufacturing and Production, Sales and Marketing Europe, Sanofi, approvals, cablivi, eu commission
Sanofi have announced that the European Commission granted marketing authorisation for Cablivi (caplacizumab) for the treatment of adults experiencing an …
Europe approves Janssen’s Darzalex in frontline multiple myeloma
September 4, 2018Manufacturing and Production, Research and Development, Sales and Marketing EU, Europe, J&J, JJ, Janssen, darzalex, multiple myeloma, pharma
Janssen has revealed that its CD38-targeting biologic drug Darzalex (daratumumab) has received approval from the European Commission, authorising its use …
Pfizer says Brexit will cost the company $100 million
September 4, 2018Manufacturing and Production EU, Pfizer, UK, brexit, pharma
The US multinational Pfizer has said that Brexit will cost the company $100 million in costs associated with the transference …
Antibiotic combinations could help in fight against antimicrobial resistance
September 4, 2018Manufacturing and Production AMR, Antibiotics, antibiotic resistance, e coli, ucla
Antimicrobial resistance (AMR) could be tackled by giving people a combination of antibiotic drugs that are no longer effective on …
Faubel-Booklet Labels
September 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Faubel-Booklet Labels with temperature indicators from ELPRO identify and monitor pharmaceutical products Melsungen, 3rd of September 2018Pharmaceutical products without proper …
Widening the focus on innovations in cancer treatment
September 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, CRUK, Cancer, GSK, diagnosis, genetics, oncology, pharma
Cancer treatment is making leaps and bounds, but public focus tends to gravitate towards the therapies themselves. Matt Fellows explores …
FDA rejects Sunovion’s ADHD drug dasotraline
September 3, 2018Sales and Marketing ADHD, FDA, dasotraline, drug, sunovion
The US Food and Drug Administration (FDA) have rejected American pharma firm Sunovion’s application to market dasotraline for the treatment …
Dutch doctors resist pharma firm’s 500-fold price hike
September 3, 2018Sales and Marketing Netherlands, leadiant, pharma, pricing
A group of Dutch doctors and health advocates are taking action against the Italian pharmaceutical firm Leadiant Biosciences who have …
The September 2018 issue of Pharmafocus is available to read online now!
September 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, AstraZeneca, Cancer, Iraw, J&J, JJ, Pfizer, Roche, UK, brexit, drug safety, pharma, pharmacovigilance
The new September edition of Pharmafocus is now live and available to read online. We’re entering the final stretch as …
AI used to forecast cancer progression
September 3, 2018Sales and Marketing AI, Cancer, ICR, London, ai drug research and development, university of edinburgh
A team of scientists at the Institute of Cancer Research (ICR) in London and the University of Edinburgh have developed …
MHRA loses EMA contracts in wake of Brexit
September 3, 2018Sales and Marketing EMA, MHRA, UK, brexit, contracts, politics, regulation
The EMA has awarded Britain’s regulatory body the MHRA just two contracts this year, as the European agency suggested that …
Top Ten most popular articles on Pharmafile.com this week
August 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Medicare, Novartis, UK, brexit, generics, king bio, pharma, top ten
Eight months of 2018 down – where has the year gone? As we move from August into September, and a …
DIA’s Global Clinical Trials Transparency Conference & Clinical Trials Regulations Conference
August 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Disclosure and transparency of clinical trial information is taking on new dimensions in the EU and US. Moreover, while the …
Global orphan and rare dermatology market set to exceed $6 billion by 2024
August 31, 2018Medical Communications Orphan Drugs, analysis, dermatology, market reports, rare diseases
The global orphan and rare dermatology premium products market is expected to grow rapidly in the next half a decade …
Shire hands over its oncology franchise to Servier for $2.4bn
August 31, 2018Medical Communications, Sales and Marketing Cancer, Servier, Shire, oncology, pharma, sale
Shire has completed the sale of its oncology franchise to French firm Servier for $2.4 billion, handing over the global …
Trump administration resists WHO efforts to tackle antimicrobial resistance
August 31, 2018Medical Communications AMR, Trump, US, US government, WHO, antimicrobial resistance
The Trump administration is in the process of drafting an alternative to the World Health Organization’s guidelines on the use …
AZ’s lupus drug fails to curb lupus activity at Phase 3
August 31, 2018Medical Communications, Research and Development AstraZeneca, Lupus, anifrolumab, pharma
AstraZeneca and its biologics R&D arm MedImmune have released a statement admitting that their fully human monoclonal antibody anifrolumab failed …
Bristol-Myers Squibb appoints Christopher Boerner as new Executive Vice President and Chief Commercial Officer
August 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, bristol myers squibb, cco, chief commercial officer, christopher boerner, executive vice president, murdo gordon
Bristol Myers Squibb has announced that Dr Christopher Boerner will take over from Murdo Gordon as executive Vice President and …
Contraceptive app Natural Cycles investigated over “misleading” efficacy claims
August 30, 2018Medical Communications, Sales and Marketing APP Pharma, Natural Cycles, UK, app. pharma
The company behind Natural Cycles, the first-ever approved smartphone app promising a natural alternative to contraception, has seen a Facebook …
Drug slows brain shrinkage associated with progressive multiple sclerosis, study shows
August 30, 2018Research and Development MS, brain, ibudilast, neuroscience, research
The multiple sclerosis drug ibudilast, slowed brain shrinkages in patients with progressive MS, a study published in the New England …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
